BENITEC INC has a total of 34 patent applications. Its first patent ever was published in 2005. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and United States. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are THERADIGM INC, KWALATA TRADING LTD and MELLO BIOTECHNOLOGY INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 6 | |
#3 | United States | 5 | |
#4 | Australia | 4 | |
#5 | Canada | 4 | |
#6 | Israel | 3 | |
#7 | China | 2 | |
#8 | Hong Kong | 1 | |
#9 | Republic of Korea | 1 | |
#10 | New Zealand | 1 | |
#11 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Object sterilising |
# | Name | Total Patents |
---|---|---|
#1 | Suhy David A | 19 |
#2 | Roelvink Petrus W | 19 |
#3 | Kolykhalov Alexander A | 19 |
#4 | Couto Linda | 11 |
#5 | Brashears Sarah J | 6 |
#6 | Evertsz Elisabeth | 6 |
#7 | Brashears Sarah | 5 |
#8 | Reed Kenneth Clifford | 4 |
#9 | Cunningham Sara M | 1 |
#10 | Giering Jeffery C | 1 |
Publication | Filing date | Title |
---|---|---|
WO2006116756A1 | Multiple-rnai expression cassettes for simultaneous delivery of rnai agents related to heterozygotic expression patterns | |
US2006189561A1 | RNAi expression constructs with liver-specific enhancer/promoter | |
NZ560936A | RNAI expression constructs | |
SG158174A1 | Rnai agents for maintenance of stem cells | |
AU2005299672A1 | Therapeutic RNAi agents for treating psoriasis | |
WO2006062581A2 | Delivery of therapeutic rnai agents for treating restenosis | |
AU2005222084A1 | Multiple promoter expression cassettes for simultaneous delivery of RNAI agents | |
CN101068926A | Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |